• Pharma
  • July 24, 2025
  • 543 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • June 17, 2025
  • 534 views
Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Telangana:  Natco Pharma has appointed Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda of the Company. Yarramshetty Krishna Rao has overall 33 years of experience in the…

  • Pharma
  • June 16, 2025
  • 517 views
Natco API plant gets one observation from FDA

Hyderabad: Drugmaker, Natco Pharma, Mekaguda-based Active Pharmaceutical Ingredients (API) plant has received one observation under the form 483 from the US Food and Drug Administration (FDA). In a stock exchange…

  • Pharma
  • June 29, 2024
  • 625 views
Natco Pharma mulling acquisition in RoW market to strengthen base business

Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business. “The acquisition space is to strengthen our base business. We have the…

  • Pharma
  • May 28, 2024
  • 492 views
BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results

Stock Market Today: Nacto Pharma share price gained almost 8% in the morning trade post Q4 results that were declared by the company post market hours on Monday. The Natco…

  • Pharma
  • December 22, 2023
  • 330 views
Anti-trust lawsuit against Natco Pharma over generic cancer drug dismissed in US

Natco Pharma on December 21  said anti-trust claims against it regarding a generic cancer treatment drug in the US have been dismissed. In September this year, the company had stated…